{"filing":{"accession_number":"0001193125-26-304789","cik":"0001831915","ticker":"CTKB","company_name":"Cytek Biosciences, Inc.","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"d99130d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1831915/000119312526304789/d99130d8k.htm"},"events":[{"id":18141,"run_id":16296,"accession_number":"0001193125-26-304789","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"The disclosure centers on compensatory arrangements for a departing officer: a severance agreement providing $365,775.12 in severance, COBRA premium coverage, conditional change-in-control benefits (18 months base salary plus 2026 bonus target), and a consulting agreement at $1,000/hour. While Valerie Barnett's departure as Chief Legal Officer occurred on June 29, 2026, the material 8-K event filed on July 15 focuses on the severance and consulting compensation arrangements negotiated on July 9, 2026, making this primarily an exec_compensation disclosure under Item 5.02(e).","company_name":"Cytek Biosciences, Inc.","ticker":"CTKB","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":16860,"accession_number":"0001193125-26-304789","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The disclosure centers on compensatory arrangements for a departing officer: a severance agreement providing $365,775.12 in severance, COBRA premium coverage, conditional change-in-control benefits (18 months base salary plus 2026 bonus target), and a consulting agreement at $1,000/hour. While Valerie Barnett's departure as Chief Legal Officer occurred on June 29, 2026, the material 8-K event filed on July 15 focuses on the severance and consulting compensation arrangements negotiated on July 9, 2026, making this primarily an exec_compensation disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T20:15:43.425213+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16860,"accession_number":"0001193125-26-304789","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The disclosure centers on compensatory arrangements for a departing officer: a severance agreement providing $365,775.12 in severance, COBRA premium coverage, conditional change-in-control benefits (18 months base salary plus 2026 bonus target), and a consulting agreement at $1,000/hour. While Valerie Barnett's departure as Chief Legal Officer occurred on June 29, 2026, the material 8-K event filed on July 15 focuses on the severance and consulting compensation arrangements negotiated on July 9, 2026, making this primarily an exec_compensation disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T20:15:43.425213+00:00","company_name":"Cytek Biosciences, Inc.","ticker":"CTKB","filing_date":"2026-07-15"}]}